Davide Tamburro - Publications

Affiliations: 
Analytical Chemistry Stockholm University, Stockholm, Stockholms län, Sweden 

14 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Fredolini C, Pathak KV, Paris L, Chapple KM, Tsantilas KA, Rosenow M, Tegeler TJ, Garcia-Mansfield K, Tamburro D, Zhou W, Russo P, Massarut S, Facchiano F, Belluco C, De Maria R, et al. Shotgun proteomics coupled to nanoparticle-based biomarker enrichment reveals a novel panel of extracellular matrix proteins as candidate serum protein biomarkers for early-stage breast cancer detection. Breast Cancer Research : Bcr. 22: 135. PMID 33267867 DOI: 10.1186/s13058-020-01373-9  0.325
2016 Petricoin EF, Ross MM, Zhou W, Tamburro D, Luchini A, Liotta LA, Herman EH, Scully RE, Miller TL, Franco VI, Sallan SE, Lipshultz SE. Development and pilot evaluation of a new nanoparticle-capture workflow for doxorubicin-induced toxicity biomarker identification Progress in Pediatric Cardiology. DOI: 10.1016/J.Ppedcard.2015.10.005  0.472
2015 Conti A, Fredolini C, Tamburro D, Magagnoli G, Zhou W, Liotta LA, Picci P, Luchini A, Benassi MS. Identification of novel candidate circulating biomarkers for malignant soft tissue sarcomas: Correlation with metastatic progression. Proteomics. PMID 26699407 DOI: 10.1002/Pmic.201500164  0.464
2015 Conti A, Fredolini C, Tamburro D, Magagnoli G, Zhou W, Liotta LA, Picci P, Luchini A, Benassi MS. Abstract 590: Identification and validation of novel candidate circulating biomarkers in high-grade soft tissue sarcoma Cancer Research. 75: 590-590. DOI: 10.1158/1538-7445.Am2015-590  0.335
2013 Bosch J, Luchini A, Pichini S, Tamburro D, Fredolini C, Liotta L, Petricoin E, Pacifici R, Facchiano F, Segura J, Garaci E, Gutiérrez-Gallego R. Analysis of urinary human growth hormone (hGH) using hydrogel nanoparticles and isoform differential immunoassays after short recombinant hGH treatment: preliminary results. Journal of Pharmaceutical and Biomedical Analysis. 85: 194-7. PMID 23954438 DOI: 10.1016/J.Jpba.2013.07.028  0.442
2012 Luchini A, Tamburro D, Magni R, Fredolini C, Espina V, Bosch J, Garaci E, Petricoin EF, Liotta LA. Application of Analyte Harvesting Nanoparticle Technology to the Measurement of Urinary HGH in Healthy Individuals. Journal of Sports Medicine & Doping Studies. 2. PMID 24014257 DOI: 10.4172/2161-0673.1000116  0.467
2012 Fredolini C, Tamburro D, Goud S, King C, Zhou W, Russo P, Espina V, Novelli F, Collura D, D'Urso L, Belluco C, Muto G, Garaci E, Liotta L, Petricoin E, et al. Abstract 4787: Novel upfront sample enrichment nanotechnology identifies prostate, breast, colon, ovarian, lung, pancreatic, and melanoma cancer specific biomarker candidates Cancer Research. 72: 4787-4787. DOI: 10.1158/1538-7445.Am2012-4787  0.44
2011 Tamburro D, Fredolini C, Espina V, Douglas TA, Ranganathan A, Ilag L, Zhou W, Russo P, Espina BH, Muto G, Petricoin EF, Liotta LA, Luchini A. Multifunctional core-shell nanoparticles: discovery of previously invisible biomarkers. Journal of the American Chemical Society. 133: 19178-88. PMID 21999289 DOI: 10.1021/Ja207515J  0.543
2011 Douglas TA, Tamburro D, Fredolini C, Espina BH, Lepene BS, Ilag L, Espina V, Petricoin EF, Liotta LA, Luchini A. The use of hydrogel microparticles to sequester and concentrate bacterial antigens in a urine test for Lyme disease. Biomaterials. 32: 1157-66. PMID 21035184 DOI: 10.1016/J.Biomaterials.2010.10.004  0.508
2010 Tamburro D, Facchiano F, Petricoin EF, Liotta LA, Zhou W. Mass spectrometry-based characterization of the vitreous phosphoproteome. Proteomics. Clinical Applications. 4: 839-46. PMID 21137027 DOI: 10.1002/Prca.201000032  0.362
2010 Fredolini C, Meani F, Luchini A, Zhou W, Russo P, Ross M, Patanarut A, Tamburro D, Gambara G, Ornstein D, Odicino F, Ragnoli M, Ravaggi A, Novelli F, Collura D, et al. Investigation of the ovarian and prostate cancer peptidome for candidate early detection markers using a novel nanoparticle biomarker capture technology. The Aaps Journal. 12: 504-18. PMID 20549403 DOI: 10.1208/S12248-010-9211-3  0.509
2010 Fredolini C, Luchini A, Meani F, Russo P, Tamburro D, Douglas T, Longo C, Gambara G, Zhou W, Ross M, Novelli F, Collura D, Muto G, Espina V, Ornstein D, et al. Abstract 4585: Verification of prostate cancer biomarker candidates by nanoparticle-capture MRM Cancer Research. 70: 4585-4585. DOI: 10.1158/1538-7445.Am10-4585  0.515
2010 Luchini A, Tamburro D, Douglas T, Espina BH, Lepene BS, Zhou W, Espina V, Petricoin EF, Liotta LA. Abstract 4575: Covalent incorporation of a new class of dye-based affinity baits in sieving hydrogel nanoparticles overcome roadblocks to cancer biomarker discovery Cancer Research. 70: 4575-4575. DOI: 10.1158/1538-7445.Am10-4575  0.469
2009 Fredolini C, Tamburro D, Gambara G, Lepene BS, Espina V, Petricoin EF, Liotta LA, Luchini A. Nanoparticle technology: amplifying the effective sensitivity of biomarker detection to create a urine test for hGH. Drug Testing and Analysis. 1: 447-54. PMID 20355230 DOI: 10.1002/Dta.96  0.518
Show low-probability matches.